MYCN and neuroblastoma: Nevertheless, by analogy with neuroblastoma and other tumors, it can be assumed that some mitotic serine/threonine kinases (AURKA, AURKB) and transcription factors (SPT16) may be involved to maintain increased expression, particularly of the N-MYC oncogene in leukemia.